Cargando…
Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has traditionally been termed senile systemic amyloidosis, while ATTRv amyloidosis has been called familial amyloid polyneuropathy. Although...
Autores principales: | Koike, Haruki, Katsuno, Masahisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466231/ https://www.ncbi.nlm.nih.gov/pubmed/30764529 http://dx.doi.org/10.3390/biomedicines7010011 |
Ejemplares similares
-
Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021) -
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
por: Koike, Haruki, et al.
Publicado: (2020) -
Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
por: Koike, Haruki, et al.
Publicado: (2021) -
Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy
por: Koike, Haruki, et al.
Publicado: (2020) -
The Ultrastructure of Tissue Damage by Amyloid Fibrils
por: Koike, Haruki, et al.
Publicado: (2021)